NYSE: DGXQuest Diagnostics Revenue
Quest Diagnostics revenue was $9.87B for the trailing 12 months ending Dec 31, 2024, with 2.5% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $2.6B, up 5.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DGX annual revenue was $9.9B, with 6.7% growth year-over-year.
DGX past revenue growth
How has DGX's revenue growth performed historically?
Company
6.7%
Industry
3.84%
Market
20.68%
DGX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DGX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DGX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
DGX revenue history
Current Revenue
$9.9B
Current Earnings
$871.0M
Current Profit Margin
8.8%
DGX's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when DGX announces revenue.
DGX Revenue History By Year
| DGX Yearly Revenue | DGX Revenue | DGX Change | DGX Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $9.87B | $620.00M | +6.70% |
| 2023-12-31 | $9.25B | -$631.00M | -6.38% |
| 2022-12-31 | $9.88B | -$905.00M | -8.39% |
| 2021-12-31 | $10.79B | $1.35B | +14.32% |
| 2020-12-31 | $9.44B | $1.71B | +22.15% |
| 2019-12-31 | $7.73B | $195.00M | +2.59% |
| 2018-12-31 | $7.53B | $129.00M | +1.74% |
| 2017-12-31 | $7.40B | $188.00M | +2.61% |
| 2016-12-31 | $7.21B | -$279.00M | -3.72% |
| 2015-12-31 | $7.49B | $58.00M | +0.78% |
| 2014-12-31 | $7.44B | $289.00M | +4.04% |
| 2013-12-31 | $7.15B | -$237.00M | -3.21% |
| 2012-12-31 | $7.38B | -$9.00M | -0.12% |
| 2011-12-31 | $7.39B | $131.88M | +1.82% |
| 2010-12-31 | $7.26B | -$195.12M | -2.62% |
| 2009-12-31 | $7.46B | $205.80M | +2.84% |
| 2008-12-31 | $7.25B | $544.54M | +8.12% |
| 2007-12-31 | $6.70B | $436.25M | +6.96% |
| 2006-12-31 | $6.27B | $811.93M | +14.88% |
| 2005-12-31 | $5.46B | $389.74M | +7.69% |
| 2004-12-31 | $5.07B | $329.03M | +6.94% |
| 2003-12-31 | $4.74B | $629.91M | +15.33% |
| 2002-12-31 | $4.11B | $480.28M | +13.24% |
| 2001-12-31 | $3.63B | $206.61M | +6.04% |
| 2000-12-31 | $3.42B | $1.22B | +55.14% |
| 1999-12-31 | $2.21B | $746.64M | +51.19% |
| 1998-12-31 | $1.46B | -$70.09M | -4.58% |
| 1997-12-31 | $1.53B | -$87.60M | -5.42% |
| 1996-12-31 | $1.62B | -$13.09M | -0.80% |
| 1995-12-31 | $1.63B | -$4.31M | -0.26% |
| 1994-12-31 | $1.63B | N/A | N/A |
Quest Diagnostics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.